Developing Personalised Relative Physical Activity Thresholds in COPD.
NCT ID: NCT06330623
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
70 participants
OBSERVATIONAL
2023-11-22
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions this study aims to answer are:
* Phase 1: What does physical activity (intensity) mean to people with COPD?
* Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD?
Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires.
Phase 2:
Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class.
Sub-study:
Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalised Exercise Training in COPD
NCT03817294
Activity, Balance and COPD (ABCOPD)
NCT04006015
Physical Activity Following Pulmonary Rehabilitation in COPD
NCT03660644
Exercise in Health and Chronic Obstructive Pulmonary Disease
NCT02300064
Physical Activity Versus Pulmonary Rehabilitation in COPD
NCT02161393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this research is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity PA in a user-friendly format for PR teams and service users.
Phase 1 objective: To explore what PA means to people with COPD in the context of relative intensity and pulmonary rehabilitation.
Phase 2 objective: To examine the differences between time spent in physical activity intensity expressed in absolute and relative terms for people with COPD.
Phase 1: Semi-structured interviews will take place where participants will discuss their COPD and their perceptions of physical activity and relative intensity. The interviews will be in person (Biomedical research centre, Leicester) or over the phone/video call. The participants will complete several questionnaires about respiratory symptoms. Before taking part in the interviews, participants will also be asked to take pictures, using a camera provided, of when they are doing physical activity. This will be for a 7 day period before the interview.
Phase 2: Participants will take part in exercise testing and complete questionnaires pre and post pulmonary rehabilitation while wearing activity and gait monitors. Participants will also be asked to wear the activity monitors for 8-days after the pre-testing sessions and 8-days after their last pulmonary rehabilitation class. Following their last pulmonary rehabilitation class, 20 participants will be asked to take photographs during the period they are wearing accelerometers and motion sensors. When the participants return the devices, they will take part in an interview to discuss the images they have taken while taking part in physical activity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase 1 Cohort
These participants will be recruited from:
* Previous research studies
* COPD nursing ward
* Pulmonary rehabilitation
No interventions assigned to this group
Phase 2 Cohort
These participants will be recruited from the pulmonary rehabilitation service.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustà et al., 2023).
* Male or female, aged 40+ years
* Able to communicate in written and spoken English.
* Willing and able to provide informed consent for participation in the research.
* The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria.
* The patient is referred for PR at the UHL.
* Male or female, aged 40+ years
* Able to communicate in written and spoken English
Exclusion Criteria
* Severe psychiatric disorders
* Aged less than 40 years
* Unable to understand written or spoken English.
Phase 2:
* Unable to provide valid informed consent.
* Lack of motivation to participate in PR programme.
* Any-contra-indications absolute or relative to exercise training.
* Has had a cardiac event within last 6 weeks
* Severe psychiatric disorders
* Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).
* Aged less than 40 years
* Unable to understand written or spoken English.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leicester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
University of Leicester University of Leicester
Role: PRINCIPAL_INVESTIGATOR
University of Leicester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIHR Leicester Biomedical Research Centre - Respiratory
Leicester, Leicestershire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
321895
Identifier Type: OTHER
Identifier Source: secondary_id
0929
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.